U.S. Entertainment Stock News

If you are wondering whether Pfizer at a last close of US$26.53 still offers solid value, the starting point is understanding what that price really implies about the business. Over the last year the stock returned 24.9%, with a 5.4% gain year to date, a 1.0% rise over the past week, and a 4.7% decline across the last 30 days, which signals that expectations and perceived risk have been shifting recently. Recent headlines have focused on Pfizer's efforts to reshape its portfolio and...

Fabrinet (FN) has just posted Q3 2026 results with revenue of US$1.2 billion, basic EPS of US$3.49 and net income of US$125.2 million, against a backdrop of 29% reported earnings growth over the last year and a trailing 12 month earnings growth rate of 19.2% per year over the past five years. The company has seen revenue move from US$871.8 million in Q3 2025 through US$909.7 million in Q4 2025 and US$978.1 million in Q1 2026 to US$1.2 billion in Q3 2026. Over the same span, basic EPS has gone...

Astera Labs (ALAB) has put up another active quarter, with Q1 2026 revenue of US$308.4 million and basic EPS of US$0.47, at a time when trailing 12 month EPS sits at US$1.59 on revenue of about US$1.0 billion and net income of US$267.6 million. This comes alongside very large year on year earnings growth and higher profit margins over the past year. Over the last five reported quarters, revenue has moved from US$159.4 million in Q1 2025 to US$308.4 million in Q1 2026, while quarterly EPS has...

Jacobs Solutions (J) opened Q2 2026 with revenue of about US$3.7b and a basic EPS loss of US$0.32, putting a negative earnings print alongside a higher top line. The company has seen quarterly revenue move from about US$2.9b in Q2 2025 to about US$3.7b in Q2 2026, while basic EPS shifted from US$0.10 in Q2 2025 to a loss of US$0.32 this quarter, setting up a mixed read on growth versus profitability that puts the spotlight firmly on margins and earnings quality. See our full analysis for...

Marqeta (MQ) has just posted its Q1 2026 scorecard, reporting revenue of US$165.8 million and basic EPS of US$0.02, with the trailing twelve months showing total revenue of US$651.6 million and basic EPS of US$0.00. Over recent quarters, revenue has ranged from US$135.8 million in Q4 2024 to US$172.1 million in Q4 2025, while quarterly basic EPS has moved from a loss of US$0.05 in Q4 2024 to a profit of US$0.02 in Q1 2026. This sets up a results season in which the key question for investors...

Edgewell Personal Care (EPC) has put fresh numbers on the table for Q2 2026, reporting revenue of US$519.5 million and basic EPS of US$0.09. This comes against a backdrop of trailing 12 month revenue of US$2.2 billion and a basic EPS loss of US$0.23. Over the past few quarters the company has seen revenue move between US$415.1 million and US$627.2 million, while basic EPS has swung from a loss of US$0.66 to a profit of US$0.62. This performance sets the scene for investors to focus on how...

Belden Inc. has reported past first-quarter 2026 results, with sales rising to US$696.38 million and GAAP diluted EPS from continuing operations at US$1.30, and has also issued second-quarter 2026 guidance for revenues of US$735 million to US$750 million and GAAP EPS of US$1.53 to US$1.63. Together with progress on its Joseph C. Belden Innovation Award finalists, these figures highlight how Belden is pairing earnings stability with initiatives that promote IT/OT convergence and data-driven...

California Resources (CRC) opened 2026 with Q1 revenue of US$967 million and a basic EPS loss of US$8.02 per share, setting a stark headline for the latest quarter. The company has seen quarterly revenue move between US$798 million and US$926 million over the last year, while EPS shifted from a profit of US$1.93 in Q2 2025 to smaller profits in subsequent quarters before this latest loss. This leaves investors weighing solid top line scale against pressure on margins. See our full analysis...

MasterBrand (MBC) opened Q1 2026 with revenue of US$618 million and a basic EPS loss of US$0.12, while trailing 12 month figures show revenue of about US$2.7 billion and a marginal basic EPS loss of US$0.02, underscoring pressure on profitability. Over recent quarters the company has seen revenue move between US$660.3 million in Q1 2025 and US$730.9 million in Q2 2025, alongside basic EPS shifting from a profit of US$0.29 in Q2 2025 to a loss of US$0.33 in Q4 2025. This sets the stage for...

Citigroup is holding its first Investor Day in four years today, where senior leaders are expected to outline new profitability targets, AI deployment plans, and updates on risk-management remediation and capital returns. This rare investor forum offers a consolidated view of how management intends to balance technology investment, operational efficiency, and shareholder returns across the global franchise. We’ll now look at how the Investor Day focus on higher profitability targets and AI...

Veracyte (VCYT) just posted Q1 2026 results with revenue of US$139.1 million and basic EPS of US$0.36, while trailing 12 month figures show revenue of US$541.7 million and basic EPS of US$1.11, alongside a 166.3% year over year earnings increase and net margins at 16.2% versus 7.1% a year earlier. Over recent quarters the company has seen revenue move from US$114.5 million in Q1 2025 to US$139.1 million in Q1 2026, with basic EPS ranging from US$0.09 to US$0.52 in interim periods. This sets...

Jazz Pharmaceuticals (JAZZ) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$4.74, setting a clear marker against last year’s volatile run of quarterly results. Over recent quarters the company has seen revenue move from US$897.8 million in Q1 2025 to US$1.09 billion in Q4 2024 and then to US$1.07 billion in Q4 2025. Basic EPS has shifted from a loss of US$1.52 per share in Q1 2025 to US$3.16 in Q4 2024 and US$3.33 in Q4 2025, leaving investors focused on how much of the...

Deluxe (DLX) opened 2026 with Q1 revenue of US$538.1 million and basic EPS of US$0.77. Trailing 12 month figures show revenue of US$2.1 billion and EPS of US$2.31, supported by 85.5% earnings growth over the past year. Over recent quarters the company has seen revenue fluctuate in a tight band between US$520.6 million and US$540.2 million, with basic EPS ranging from US$0.26 to US$0.77, and net profit margins over the last 12 months running at 4.9% versus 2.6% in the prior year. This sets up...

If you are wondering whether L3Harris Technologies at around US$302 a share looks expensive or attractive, the next step is to line that price up against what the business might reasonably be worth. The stock has seen a 6.0% decline over the last 7 days and a 15.8% decline over the last 30 days, even though the 1 year return sits at 41.0% and the 3 year return at 70.1%. Recent headlines have focused on L3Harris Technologies as a key player in aerospace and defense programs and contract...

Vontier (NYSE:VNT) highlighted its multi energy fleet technology strategy at ACT Expo 2026. The company presented an integrated platform that combines traditional and new energy refueling, EV management, diagnostics, payment security, and telematics. The event showcased new solutions aimed at supporting fleet decarbonization and digital transformation. For investors tracking the fleet and mobility sector, Vontier sits at the intersection of hardware, software, and services for...

Kyndryl Holdings (KD) just closed FY 2026 with fourth quarter revenue of US$3.8b and basic EPS of US$0.08, alongside trailing 12 month revenue of US$15.1b and EPS of US$0.87 that frame the full year picture. Over recent quarters, revenue has moved in a tight band from US$3.7b to US$3.9b while quarterly EPS has ranged from US$0.24 to US$0.29 before landing at US$0.08 in Q4, giving you a clear sense of how earnings have tracked against a largely steady top line. With a trailing net profit...

Primoris Services (PRIM) opened 2026 with Q1 revenue of US$1.6b and basic EPS of US$0.32, setting the tone for how its construction and infrastructure pipeline is feeding through to the bottom line. Over the past year, revenue has moved from US$1.6b in Q1 2025 to US$1.9b in Q2 2025, US$2.2b in Q3 2025, US$1.9b in Q4 2025 and US$1.6b in Q1 2026, while quarterly basic EPS has ranged from US$0.82 to US$1.75 across those periods. For investors, a key focus is how these volumes are translating...

Qorvo (QRVO) has just closed out FY 2026 with fourth quarter revenue of US$808.3 million and basic EPS of US$0.32, capping a year in which trailing twelve month revenue reached about US$3.7 billion and EPS came in at US$3.66. Over recent quarters the company has seen revenue range from US$808.3 million to US$1.1 billion and basic EPS move between US$0.28 and US$1.77, with trailing net income over the last twelve months totaling US$339.0 million. For investors, the key takeaway is that margins...

InTest (INTT) opened 2026 with Q1 revenue of US$33.9 million and basic EPS of US$0.06, while the trailing twelve months show total revenue of US$121.1 million and basic EPS of US$0.05, giving investors a clear snapshot of current scale and per share profitability. The company has seen quarterly revenue move from US$26.6 million in Q1 2025 to US$33.9 million in Q1 2026, with basic EPS shifting from a loss of US$0.19 to a profit of US$0.06 over the same period. This sets up a results season...

Coherent (NYSE:COHR) announced that Chief Strategy Officer Giovanni Barbarossa will transition from his role and retire in September 2026. Barbarossa will serve as Special Advisor to the CEO until his retirement, supporting continuity during the leadership change. The announcement comes alongside Coherent reporting revenue and earnings growth across its business. Coherent is a supplier of advanced optics and laser technologies that are used in AI infrastructure, communications, and...

QuidelOrtho (QDEL) opened Q1 2026 with revenue of US$619.8 million and a basic EPS loss of US$1.35, while trailing 12 month figures show revenue of US$2.66 billion against a basic EPS loss of US$17.81. Over the past six reported quarters, revenue has ranged from US$613.9 million to US$723.6 million, and quarterly basic EPS has moved between a loss of US$0.19 and a loss of US$10.78. This leaves investors focused on how much of today’s revenue base can ultimately translate into more stable...

Kinder Morgan (NYSE:KMI) is facing a lawsuit in Texas alleging gross negligence after a pipeline explosion that severely injured a worker. The legal action claims inadequate safety protocols and seeks to preserve the explosion site for investigation under a temporary restraining order. The case focuses on operational safety practices and potential liability exposure for the pipeline operator. Kinder Morgan operates energy infrastructure assets, including pipelines that transport natural gas...

Hinge Health (HNGE) opened Q1 2026 with revenue of $182.3 million and basic EPS of $0.43, providing a clear view of how the business is currently converting its top line into per share results. Over the past year, the company has reported quarterly revenue of $117.3 million in Q4 2024, $123.8 million in Q1 2025, $139.1 million in Q2 2025, $154.2 million in Q3 2025, $170.7 million in Q4 2025 and now $182.3 million in Q1 2026. Basic EPS over the same period has ranged from $1.98 to $7.38,...

Phibro Animal Health Corporation has reported its third-quarter 2026 results, with sales of US$383.54 million and net income of US$24.02 million, alongside the launch of its Sustainable Solutions Platform and Verratain™ low‑carbon feed products in partnership with VAXA Technologies. The combination of stronger earnings and a companywide push into emissions‑focused feed ingredients suggests Phibro is tying profitability more closely to sustainability trends across animal protein and petfood...